Oxford University hails partnership as ‘step forward in cancer research’

Good morning, and welcome to our rolling coverage of business, the financial markets and the world economy.

Britain’s second-biggest drugmaker GSK has struck a deal with the University of Oxford under which it will pump up to £50m into early cancer research to develop new treatments.

We’re pleased to further strengthen our relationship with Oxford University and to combine the deep knowledge of Oxford and GSK scientists. By exploring precancer biology and building on GSK’s expertise in the science of the immune system, we aim to generate key insights for people at risk of developing cancer.

9am GMT: Germany Ifo Business confidence for January

3pm GMT: US New home sales for December

3.35pm GMT: ECB President Christine Lagarde speaks